Photochemistry of Imidacloprid in Model Systems
J. Agric. Food Chem., Vol. 56, No. 17, 2008 8025
methanol) used for LC separation, all LC parameters remained the same
as for HPLC/DAD analysis. MS parameters were as follows: ESI+;
source temperature, 120 °C; capillary 3.5 kV; HV lens 0.5 kV; cone
ramp 20-60 V. MS was operated in full-scan mode (m/z 80-1200).
For data acquisition and processing, MassLynx 3.2 software was
employed.
(br, s), 2900 (m), 1663 (s), 1618 (m), 1564 (s), 1452 (m), 1383 (m),
1358 (m), 1306 (w), 1285 (m), 1244 (m), 1209 (m), 1139 (m), 1110
(s), 1097 (s), 1025 (m), 966 (w), 931 (w), 848 (m), 804 (m), 738 (s),
697 (m), 674 (s). UV (methanol): λmax ) 207 (log ε ) 4.30), 268 nm
(log ε ) 3.45).
1-[(6-Chloropyridin-3-yl)methyl]imidazolidin-2-one (2) was synthe-
sized by reaction of 200 mg (0.78 mmol) of imidacloprid with 20 mL
of an aqueous potassium hydroxide solution (40 g/L) for 1 h at 100 °C
according to Rouchaud et al. (20) (yield: 58.6 mg, 35% of theory).
For the preparation of 1-[(6-chloropyridin-3-yl)methyl]imidazolidin-
2-one oxohydrazone (6), 100 mg (0.39 mmol) of imidacloprid was
reduced with 150 mg of iron powder (pure, Sigma-Aldrich, Munich,
Germany) in 50 mL of an aqueous ammonium chloride solution (11
mM). After stirring for 2 h at room temperature, the reaction batch
was filtered, and water was evaporated at reduced pressure (30 mbar,
40 °C). The residue was purified by HSCCC. The fraction of 185-225
mL was collected, the organic solvents were evaporated in vacuo, and
the remaining aqueous solution was lyophilized to yield 28 mg of yellow
crystals (30% of theory; melting point 146 °C under decomposition).
LC/MS (ESI+): m/z 262 ([M + Na]+, 10%), 278 ([M + K]+, 6%),
240 ([M + H]+, 100%), 210 ([M + H - NO]+•, 45%), 209 ([M + H
- HNO]+, 12%), 175 ([M + H - NO - Cl]+, 6%). UV (methanol):
λmax ) 212 (log ε ) 3.99), 269 nm (log ε ) 4.28).
Methyl 9,10-epoxystearate was synthesized by the reaction of 1.0 g
(3.2 mmol) of methyl oleate (Sigma-Aldrich, Munich, Germany) with
3 mL of peracetic acid (32% in dilute acetic acid, Sigma-Aldrich) in 5
mL of diethyl ether for 20 h at room temperature. The reaction batch
was poured in 20 mL of a saturated potassium carbonate solution and
extracted three times with 10 mL of diethyl ether. The organic extract
was dried over anhydrous sodium sulfate (Merck, Darmstadt, Germany),
and the solvent was evaporated resulting in 532 mg of a colorless oil
(50,4% of theory).
For kinetic studies, a solution of 10 mg (0.048 mmol) of 1-[(6-
chloropyridin-3-yl)methyl]imidazolidin-2-imine (5) and 500 µL (4.95
mmol) of cyclohexene oxide in 2 mL of methanol was stirred at ambient
temperature in the dark for 14 days. Samples of 10 µL were taken,
diluted with 990 µL of methanol, and analyzed by HPLC. In a
preparative scale, 101 mg (0.48 mmol) of 5 was dissolved in 20 mL of
methanol, 5 mL (49.5 mmol) of cyclohexene oxide were added, and
the reaction batch was stirred at 50 °C for 3 days. The mixture was
concentrated under vacuum to 5 mL, and 5 mL of ammonium formate
buffer (10 mM, pH 4.0) was added. Separation by preparative HPLC
yielded two fractions at 9.0 min (16, 78 mg, 52.8% of theory) and
10.5 min (17, 5.6 mg, 3.8% of theory).
2-({1-[(6-Chloropyridin-3-yl)methyl]imidazolidin-2-ylidene}amino)-
cyclohexanol (16); LC/MS (ESI+): m/z 309 [M + H]+; accurate mass
calculated for C15H22N4OCl ([M + H]+) 309.1482, found 309.1472.
1H NMR (d4-methanol): δ (ppm) ) 8.39 (m, 2H), 7.84 (m, 2H), 7.54
(m, 2H), 4.74-4.60 (m, 4H), 3.77-3.55 (m, 8H), 3.55-3.43 (m, 2H),
3.32-3.21 (m, 2H), 2.16-1.90 (m, 4H), 1.90-1.74 (m, 4H), 1.32-1.24
(m, 8H). 13C NMR (d4-methanol): δ (ppm) ) 158.9, 158.1, 151.0,
148.9, 148.9, 139.2, 139.2, 130.6, 130.5, 124.8, 75.0, 73.0, 69.1, 60.2,
60.0, 47.8, 45.8, 45.7, 45.2, 41.0, 34.4, 33.0, 31.4, 28.2, 24.6, 24.5,
24.2, 24.1, 24.0. UV (methanol/phosphate buffer, from DAD spectra):
λmax ) 214, 269 nm.
An LCT Premier XE LC/TOF-MS system (Waters, Manchester,
U.K.) was used for the determination of accurate masses.
Preparative HPLC was carried out on a system consisting of two
pumps (Kronlab, Sinsheim, Germany), an A 0293 variable-wavelength
monitor (Knauer, Berlin, Germany), a C-R3A integrator (Shimadzu,
Duisburg, Germany), and a YMC HPLC column (guard column 50
mm × 20 mm; column, 250 mm × 20 mm; YMC-Pack ODS-A, 10
µm); a gradient system consisting of ammonium formate buffer (10
mM, pH 4.0) and methanol as eluents (flow rate ) 20 mL/min), with
gradient as above, was used. Pump flow and gradient were controlled
by Prepcon software (SCPA GmbH, Weyhe-Leeste, Germany).
High-speed countercurrent chromatography (HSCCC) was performed
with a model CCC-1000 (Pharma-Tech Research Corp., Baltimore,
Maryland) connected to a A 0293 variable wavelength monitor
(detection at 270 nm, Knauer, Berlin, Germany) and a multirange BD
8 recorder (Kipp & Zonen, Delft, Netherlands). The two-phase solvent
system consisted of water/ethyl acetate/n-hexane/1-butanol (10/8/1/0.5;
v/v/v/v) and was pumped into the column with a Knauer HPLC pump
64 equipped with a preparative pump head. The lower phase was used
as mobile phase and was introduced through the head toward the tail
with a flow rate of 1.5 mL/min. The revolution speed was set at 1000
rpm. Fractions of 5 mL were collected with a Retriever 500 (ISCO,
Lincoln, Nebraska).
Ultraviolet spectra were measured from 190 to 400 nm with a Cary
1E spectrophotometer (Varian, Darmstadt, Germany) using quartz glass
cuvettes; scan rate: 60 nm/min; ave time: 0.1 s; data intervall: 0.1 nm.
1H and 13C nuclear magnetic resonance (NMR) spectra were obtained
using a Unity Inova 300 spectrometer (Varian, Darmstadt, Germany)
at 298 K at 300 and 75 MHz (nominal frequency), respectively, in
dimethyl-d6-sulfoxide (d6-DMSO) or d4-methanol. Chemical shifts are
given in δ (ppm) relative to trimethylsilane (TMS).
An infrared attenuated total reflectance (IR-ATR) spectrum was
recorded on a Fourier transform infrared (FT-IR) spectrometer Nicolet
Avatar 320 ESP (Thermo Electron, Dreieich, Germany).
Melting points were determined on a digital melting point apparatus
model 8100 (Electrothermal, Southend-on-Sea, U.K.) and are not
corrected.
For irradiation experiments in solutions, a metal halogen lamp (SOL
500, Dr. K. Ho¨nle GmbH, Martinsried, Germany; 120 000 lx, 900
W/m2) with a glass filter WG 295 (Schott Glaswerke, Mainz, Germany,
λ > 280 nm) was used. Irradiation on glass surfaces was performed
under a Suntest CPS + (Heraeus-Industrietechnik, Kleinostheim,
Germany) with a xenon lamp, UV filters (λ > 290 nm) and air cooling;
standard black temperature: 35 °C; irradiance: 250 W/m2.
Syntheses. Synthesis of 1-[(6-chloropyridin-3-yl)methyl]imidazoli-
din-2-imine (5) was performed following a modified procedure of
Hayakawa et al. (19). In a 100 mL screw-capped bottle, 400 mg of
imidacloprid (1.56 mmol) and 800 mg of stannous(II) chloride dihydrate
(3.54 mmol, analytical grade, Merck, Darmstadt, Germany) in 75 mL
of formic acid (98-100%, analytical grade, Merck, Darmstadt) were
heated at 100 °C for 4 h. After cooling, the reaction batch was
transferred into a 250 mL round-bottomed flask; 20 g of silica gel 60
(0.063-0.200 nm, for column chromatography, Merck, Darmstadt) was
added, and formic acid was distilled off on a rotary evaporator under
reduced pressure (40 mbar, 40 °C). The residue was suspended in 40
mL of ethyl acetate and transferred into a glass column (3 cm × 40
cm); the product was eluted with ethyl acetate/methanol (1/1, v/v).
Fractions of 10 mL were analyzed by TLC, and the ones containing 5
(Rf value ) 0.05) were combined. The residue obtained after evapora-
tion was recrystallized from ethanol to yield 180 mg of colorless crystals
(55% of theory; melting point 250 °C under decomposition). LC/MS
2-({1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-ylidene}amino)-
cyclohexanone (17); LC/MS (ESI+): m/z 307 [M + H]+; accurate mass
calculated for C15H20N4OCl ([M + H]+) 307.1326, found 307.1321.
1H NMR (d4-methanol): δ (ppm) ) 8.36 (m, 1H), 7.80 (m, 1H), 7.52
(m, 1H), 4.67-4.56 (m, 2H), 3.75-3.56 (m, 4H), 3.89 (m, 1H),
2.08-1.95 (m, 4H), 1.88-1.78 (m, 2H), 1.61-1.42 (m, 2H); 13C NMR
(d4-methanol): δ (ppm) ) 155.6, 151.2, 149.0, 139.3, 130.4, 124.8,
81.4, 51.3, 46.6, 44.6, 45.2, 39.0, 36.6, 27.0, 18.3. UV (methanol/
phosphate buffer, from DAD spectra): λmax ) 213, 269 nm.
Methyl-9,10-epoxystearate (105 mg, 0.336 mmol) and 5 (3 mg, 0.014
mmol) were dissolved in 5 mL of methanol and heated under reflux
for 24 h. The reaction mixture (10 µL) was directly injected into the
LC/MS system.
1
(ESI+): m/z 211 ([M + H]+). H NMR (d6-DMSO): δ (ppm) ) 8.39
(m, 1H), 7.81 (m, 1H), 7.56 (m, 1H), 4.56 (s, 2H), 3.34-3.53 (m, 4H).
13C NMR (DMSO-d6): δ (ppm) ) 160.3, 150.5, 150.0, 140.1, 131.6,
125.1, 47.7, 45.0, 41.1. IR (ATR, cm-1) 3347 (w), 3130 (sh), 3037
Irradiation experiments. Imidacloprid (15 mg, 0.058 mmol) were
dissolved in 50 mL of methanol, ethanol, 2-propanol, cyclohexane/
ethanol, or cyclohexene/ethanol (20 vol% ethanol to improve solubility).